Trastuzumab and Biosimilars

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.101" ]
    } ]
  },
  "date" : "2020-09-02T01:00:26-04:00",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent the medication Trastuzumab and Trastuzumab biosimilars.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Trastuzumab and Trastuzumab biosimilars.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
  "name" : "TrastuzumabAndBiosimilars",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1658084",
      "display" : "ado-trastuzumab emtansine 100 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1658089",
      "display" : "ado-trastuzumab emtansine 160 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1922509",
      "display" : "trastuzumab 150 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1922516",
      "display" : "trastuzumab 21 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2107053",
      "display" : "trastuzumab-pkrb 21 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2119714",
      "display" : "5 ML hyaluronidase-oysk 2000 UNT/ML / trastuzumab-oysk 120 MG/ML Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2169359",
      "display" : "trastuzumab-pkrb 150 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2174804",
      "display" : "trastuzumab-anns 21 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2179753",
      "display" : "trastuzumab-dkst 150 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2179760",
      "display" : "trastuzumab-dkst 21 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2257297",
      "display" : "trastuzumab-anns 150 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2267576",
      "display" : "fam-trastuzumab deruxtecan-nxki 100 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2280732",
      "display" : "trastuzumab-qyyp 21 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2289227",
      "display" : "trastuzumab-dttb 150 MG Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2289234",
      "display" : "trastuzumab-dttb 21 MG/ML Injectable Solution",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2382604",
      "display" : "15 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 80 MG/ML / trastuzumab-zzxf 40 MG/ML Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2383305",
      "display" : "10 ML hyaluronidase-zzxf 2000 UNT/ML / pertuzumab-zzxf 60 MG/ML / trastuzumab-zzxf 60 MG/ML Injection",
      "version" : "04012024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "2472791",
      "display" : "trastuzumab-qyyp 150 MG Injection",
      "version" : "04012024"
    } ],
    "total" : 18,
    "identifier" : "urn:uuid:467c2971-6e41-4774-b521-9c1fca01384b",
    "timestamp" : "2024-04-23T13:43:43-04:00"
  },
  "title" : "Trastuzumab and Biosimilars",
  "extension" : [ {
    "valueString" : "American Society of Clinical Oncology Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2023-07-06",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2020-09-02",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "032d9d0e-b450-4330-abc5-36e56e25a7f1",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.206",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.1444.5.206"
  } ],
  "version" : "20200902"
}